Interpace Biosciences (IDXG) Reports Q3 EPS of $0.31

Interpace Biosciences (OTC: IDXG) reported Q3 EPS of $0.31. Revenue for the quarter came in at $12.3 million.

For earnings history and earnings-related data on Interpace Biosciences (IDXG) click here.

You May Also Be Interested In

• BofA says convenience store sales trail broader retail channels
• The free USDA tool that tracks egg prices at $0.62/dozen before your data vendor does
• Ishares Iboxx $ Investment Grade Corporate Bond Etf (LQD) spreader of 4K contracts of October 105 puts and 4K contracts of October 106 calls